Fund 13F filing

JPMorgan Chase added $40.9M of Seaport Therapeutics, Inc. (SPTX) stock

SEC Form 13F · Filed Aug 12, 2026

JPMorgan Chase added $40.9M of Seaport Therapeutics, Inc. (SPTX) stock in the quarter ending Jun 30, 2026, per a 13F filed Aug 12, 2026.

A 13F shows holdings at quarter end, so the exact trade dates are not disclosed.

Bought

Seaport Therapeutics, Inc.

Value

$40.9M

More SPTX insider and Congress trades

Share this trade

From a public SEC Form 13F, linked above. Not investment advice, and not a recommendation to buy or sell.